Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1992-2-27
pubmed:abstractText
Transgenic mice that contain constructs of the L-myc gene under the transcriptional control of the immunoglobulin heavy chain enhancer (E mu) develop thymic hyperplasia and are predisposed to T cell lymphomas. Here we describe a second form of malignancy that occurs in aging E mu L-myc transgenic mice. The mean latency period for the development of this malignancy is longer compared with the E mu L-myc T cell lymphomas but the overall incidence is increased threefold. The histopathological morphology is that of a highly malignant mesenchymal neoplasm that closely resembles human fibrous histiocytoma. The tumor cells were classified as myelomonocytic on the basis of several lineage-specific markers and the lack of rearrangements of the immunoglobulin heavy chain and the T cell receptor beta loci. Cultured tumor cells produce macrophage colony-stimulating factor (M-CSF) protein and express the M-CSF receptor, suggesting the involvement of an autocrine loop in this malignancy. Similar to the E mu L-myc T cell lymphomas, these tumors show high-level transgene expression but no detectable levels of endogenous c-myc mRNA, directly implicating the deregulated expression of L-myc in the generation of this malignancy. E mu L-myc myelomonocytic tumors show consistent trisomy of chromosome 16, implicating this as a secondary event in the development of this tumor. In the light of recent findings that L-myc is expressed in human myeloid leukemias and in several human myeloid tumor cell lines, the results described here might implicate L-myc in the development of naturally occurring myeloid neoplasias.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-115001, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-1986238, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2091750, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2120050, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2160584, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2205804, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2251503, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2419762, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2430692, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2454746, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2457153, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2471131, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2501083, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2504875, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2548143, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2653809, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2785918, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2827002, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2828024, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2832150, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2869488, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2906111, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-2966922, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3016297, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3025854, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3034500, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3049618, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-309097, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3135366, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-316545, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3215058, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3261863, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3299052, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3322939, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3547079, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3860871, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-3906410, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-4040214, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6098468, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6205276, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6291785, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6292525, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6308472, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6505694, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6611207, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6728001, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6769117, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6787590, http://linkedlifedata.com/resource/pubmed/commentcorrection/1310099-6888561
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
175
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
313-22
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.
More...